The U.S. District Court for the District of New Jersey ruled Lilly's method-of-use patent for Strattera, which had been set to expire in 2017, was invalid.
美国新泽西区地方法院已经做出裁决，认定礼来公司将于2017年过期的Strattera药物专利是无效的。
The U.S. District Court for the District of New Jersey ruled Lilly's method-of-use patent for Strattera, which had been set to expire in 2017, was invalid.
美国新泽西区地方法院已经做出裁决，认定礼来公司将于2017年过期的Strattera药物专利是无效的。
应用推荐